Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer
HYPNOSEIN
1 other identifier
interventional
30
1 country
3
Brief Summary
The emergence of cognitive disorders after surgery under general anesthesia (GA) is the second leading cause of patient complaints (after dental debris caused by intubation techniques). These cognitive disorders can range from simple reversible confusion (26%) with postoperative cognitive dysfunction without actual recovery (10%). The hypnosedation is an ancient technique of anesthesia expanding its effects on cognitive function remain to this day unknown, but appear promising.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2010
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 6, 2012
CompletedFirst Posted
Study publicly available on registry
June 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedResults Posted
Study results publicly available
March 4, 2022
CompletedMarch 4, 2022
December 1, 2021
5.9 years
November 6, 2012
December 10, 2021
March 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of Cognitive Impairment
Cognitive impairment is assessed using the MMSE questionnaire (MINI-MENTAL STATE EXAMINATION). the MMSE total score ranges from 0 (alteration of cognition) to 30 (no alteration)
on the 7th day following surgery
Secondary Outcomes (1)
Presence of Cognitive Impairment
1 month after surgery
Study Arms (2)
hypnosedation
EXPERIMENTALhypnosedation
general anesthesia
OTHERgeneral anesthesia
Interventions
Eligibility Criteria
You may qualify if:
- Female, over 18 and under 80 years
- Diagnosis of breast cancer established (Pathology)
- Life expectancy greater than 6 months
- Surgery of breast lumpectomy with or without lymph node dissection, mastectomy with or without lymph node dissection, dissection isolated
- ASA 1 (healthy patient) or 2 (patient with moderate to high function) according to the classification of the American Society of Anesthesiologist,
- Affiliation to a social security scheme,
- Information on the study, signed informed consent
You may not qualify if:
- Presence of major psychiatric disorders or psychotic behavior addiction, evaluated by neuropsychologist at the first preoperative consultation, through the test MINI (MINI\> 4 positive responses for each module)
- Presence of neurological disorders known untreated or evaluated by neuropsychologist at the first preoperative consultation, with the MMSE test (MMSE \<24)
- Patient treated morphine orally for 3 months or more
- Patient is pregnant or nursing, or of childbearing potential and not using adequate contraception,
- Patient included in another clinical study
- Inability to undergo medical monitoring study for geographical, social or psychological
- Patient deprived of liberty and most subject to a measure of legal protection or unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Centre Paul Strauss
Strasbourg, Alsace, 67000, France
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
Centre Oscar Lambret
Lille, Nord, 59000, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pr Simone Mathoulin-Pélissier
- Organization
- Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR
Study Officials
- STUDY CHAIR
COLOMBANI Sylvie, MD
Institut Bergonié
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2012
First Posted
June 19, 2013
Study Start
December 1, 2010
Primary Completion
November 1, 2016
Study Completion
December 1, 2017
Last Updated
March 4, 2022
Results First Posted
March 4, 2022
Record last verified: 2021-12